$0.35▴ 0.00%
End-of-day close · 2026-05-13
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Reviva Pharmaceuticals Holdings, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days19 articles
15 bullish4 neutral0 bearish
Want Passive Income for Life? Here Are 2 Dividend Stocks to Buy and Never SellComplicated Urinary Tract Infections Market Set for Expansion by 2036, Supported by Recent Drug Approvals Including GSK/Spero Therapeutics’ UTEBZI and Wockhardt’s ZAYNICH and Emerging Therapies | DelveInsight
2 Dividend Stocks Worth Holding Forever (Including 1 Dividend King)
The "Trumpflation" Trade Could Get Worse Before It Gets Better. History Says These 2 Stocks Are the Place to Hide.Freehand CEO Nitin Jayakrishnan Addresses Supply Chain Disruption and Resilience at LogiPharma USA 2026